Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This trial is conducted in Europe.
The aim of this trial is to compare the efficacy and safety of insulin detemir and insulin NPH in adults with type 1 diabetes on blood glucose control.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| insulin detemir | Drug | |||
| insulin NPH | Drug | |||
| insulin aspart | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| HbA1c | after 26 weeks of treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Plasma glucose profiles | ||
| Change in body weight | ||
| Quality of Life |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Global Clinical Registry (GCR, 1452) | Novo Nordisk A/S | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Novo Nordisk Investigational Site | Amersfoort | 3818 ES | Netherlands | |||
| Novo Nordisk Investigational Site |
Not provided
| Label | URL |
|---|---|
| Clinical Trials at Novo Nordisk | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Incidence of adverse events |
| Incidence of hypoglycaemic episodes |
| Apeldoorn |
| 7334 DZ |
| Netherlands |
| Novo Nordisk Investigational Site | Den Helder | 1782 GZ | Netherlands |
| Novo Nordisk Investigational Site | Deventer | 7415 CM | Netherlands |
| Novo Nordisk Investigational Site | Enschede | 7511 JX | Netherlands |
| Novo Nordisk Investigational Site | Gouda | 2805 AH | Netherlands |
| Novo Nordisk Investigational Site | Hoogeveen | 7909 AA | Netherlands |
| Novo Nordisk Investigational Site | Leidschendam | 2262 BA | Netherlands |
| Novo Nordisk Investigational Site | Meppel | 7943 KA | Netherlands |
| Novo Nordisk Investigational Site | Rotterdam | 3083 AN | Netherlands |
| Novo Nordisk Investigational Site | Stadskanaal | 9501 EH | Netherlands |
| Novo Nordisk Investigational Site | The Hague | 2566 MJ | Netherlands |
| Novo Nordisk Investigational Site | The Hague | 2597 AX | Netherlands |
| Novo Nordisk Investigational Site | Utrecht | 3563 AZ | Netherlands |
| Novo Nordisk Investigational Site | Waalwijk | 5141 BM | Netherlands |
| Novo Nordisk Investigational Site | Weert | 6001 BE | Netherlands |
| Novo Nordisk Investigational Site | Zevenaar | 6903 ZN | Netherlands |
| Novo Nordisk Investigational Site | Zwolle | 8025 AB | Netherlands |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D003922 | Diabetes Mellitus, Type 1 |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069057 | Insulin Detemir |
| D007336 | Insulin, Isophane |
| D061267 | Insulin Aspart |
| ID | Term |
|---|---|
| D049528 | Insulin, Long-Acting |
| D061385 | Insulins |
| D010187 | Pancreatic Hormones |
| D036361 | Peptide Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D061266 | Insulin, Short-Acting |
Not provided
Not provided